Combined Pituitary Hormone Deficiency: Clinical Trials

11 trials for Combined Pituitary Hormone Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 4 Phase 4, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4
Early Phase 11Unknown 1
Not applicable1Not yet recruiting 1

Follow Combined Pituitary Hormone Deficiency: new trials by email Literature Review of Combined Pituitary Hormone Deficiency trials Research Report on Combined Pituitary Hormone Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Growing up With the Young Endocrine Support System (YESS!)
YESS! game, Snake '97, Transition-toolkit - Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism
Not applicableNot yet recruitingdr. Laura C. G. de Graaff-Herder1602024-12-012023-09-07
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Saxenda - Panhypopituitarism, Craniopharyngioma
Early Phase 1UnknownSeoul National University Hospital502022-11-282024-01-23
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Experimental: GLP1-RA (exenatide) administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau422021-09-132026-01-20
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
Experimental: CRH administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau522021-07-062024-04-03
Incidence of cCPHD in Denmark - a National Observational Study
Combined Pituitary Hormone Deficiency Genetic Form, Combined Pituitary Hormone Deficiency
UnknownOdense University Hospital1272021-02-012022-07-07
Growth Hormone and Endothelial Function in Children
growth hormone - Growth Hormone Deficiency, Panhypopituitarism
Phase 4CompletedOhio State University92005-01-012018-05-30
Testosterone Gel Applied to Women With Pituitary Gland Problems
Transdermal Testosterone gel - Panhypopituitarism
Phase 4CompletedCharles Drew University of Medicine and Science202003-07-012017-06-27
Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism
Panhypopituitarism
WithdrawnCharles Drew University of Medicine and Science2002-08-012017-04-18
Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma
Different surgical approach and techniques being used to treat three subtype of CP - Craniopharyngioma
UnknownSouthern Medical University, China2381997-09-012010-09-15
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Tissue specimen collection, MRI - Panhypopituitarism, Gigantism/Acromegaly
RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)20001997-04-212026-10-19

Narrower conditions

Adrenal Hyperplasia, Congenital (2)  ·  Craniopharyngioma (2)  ·  Diabetes Insipidus, Neurogenic (2)  ·  Dwarfism, Pituitary (2)  ·  Hypopituitarism (2)  ·  Hypothalamic Diseases (2)  ·  Mental Disorders (2)  ·  Pituitary Diseases (2)  ·  Social Isolation (2)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)  ·  3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (1)  ·  Acidemia, isovaleric (1)  ·  Acromegaly (1)  ·  Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1)

Broader conditions

Endocrine System Diseases (7)  ·  Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Nervous System Diseases (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Urogenital Diseases (5)  ·  Bone Diseases (4)  ·  Bone Diseases, Developmental (4)  ·  Bone Diseases, Endocrine (4)  ·  Musculoskeletal Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)

Interventions

Exenatide (1)  ·  Growth Hormone (1)  ·  Liraglutide (1)  ·  Organization and Administration (1)  ·  Sodium Chloride (1)  ·  Tissue Banks (1)

Sponsors

Charles Drew University of Medicine and Science (2)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Odense University Hospital (1)  ·  Ohio State University (1)  ·  Seoul National University Hospital (1)  ·  Southern Medical University, China (1)  ·  dr. Laura C. G. de Graaff-Herder (1)

Countries

United States (4)  ·  Spain (3)  ·  Belgium (2)  ·  China (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Anna Aulinas, MD PhD (2)  ·  Deborah P Merke, M.D. (1)  ·  Henrik T Christesen, ph.d. (1)  ·  Laura CG de Graaff, MD PhD (1)  ·  Laurent Servais (1)  ·  Robert P Hoffman, MD (1)  ·  Songtao Qi, MD, PhD (1)  ·  Ted C Friedman, M.D., Ph.D. (1)  ·  Theodore C Friedman, M.D., Ph.D. (1)

Results publications

PMID 19170709, PMID 19344074, PMID 22154461, PMID 24412141, PMID 25258026, PMID 27496264, PMID 29395172, PMID 30234410, PMID 31853886, PMID 32232325, PMID 32714280, PMID 36149413, PMID 37043518, PMID 39824923, PMID 40813536, PMID 41349930, PMID 41540017

NIH funding

U54HD041748 (1)